Any effort to address the ethical questions outlined in this paper will involve two institutional stages: 1) hearings by a Parliamentary committee given a mandate specifically to examine the ethical issues associated with the patenting of higher life forms and to recommend legislative, regulatory and policy changes; 2) a key ethical question addressed should be whether the baseline or starting point for decisions about patenting higher life forms should be a presumption in favour of patenting or a presumption against it.